{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:28:01Z","timestamp":1787120881622,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    The increasing prevalence of multidrug-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    continues to compromise the effectiveness of conventional antimicrobial therapy and highlights the need for novel adjunctive treatment strategies. Despite the traditional medicinal use of\n                    <jats:italic>Zanthoxylum<\/jats:italic>\n                    species, the antibacterial potential of\n                    <jats:italic>Zanthoxylum beecheyanum<\/jats:italic>\n                    remains largely unexplored. Here, we characterized the chemical composition of\n                    <jats:italic>Zanthoxylum beecheyanum<\/jats:italic>\n                    essential oil (ZBEO) and evaluated its antibacterial activity against a panel of clinically relevant\n                    <jats:italic>S. aureus<\/jats:italic>\n                    strains, its ability to potentiate vancomycin activity, and its effects on biofilm formation. GC-MS profiling identified D-limonene and methyl cinnamate as the predominant volatile metabolites. ZBEO exhibited antibacterial activity against all tested strains, with MIC values ranging from 8 to 128\u00a0mg\/L. Checkerboard assays demonstrated synergistic effects between ZBEO and vancomycin, with fractional inhibitory concentration index values as low as 0.375. Time-kill assays showed that ZBEO exhibited antibacterial activity as monotherapy and, in combination, enhanced bacterial killing and reduced bacterial regrowth compared with vancomycin alone. In addition, ZBEO inhibited biofilm formation in a concentration-dependent manner, with the greatest activity observed during combination treatment with vancomycin. Preliminary safety assessment demonstrated low hemolytic activity and limited cytotoxicity toward HEK-293 cells (CC\n                    <jats:sub>50<\/jats:sub>\n                    &amp;gt; 128\u00a0mg\/L) within the antibacterial concentration range. These findings identify ZBEO as a promising adjunct to vancomycin for enhancing antibacterial activity and inhibiting\n                    <jats:italic>S. aureus<\/jats:italic>\n                    biofilm formation, warranting further investigation as a plant derived adjunctive therapy for difficult-to-treat staphylococcal infections.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1919407","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:48:22Z","timestamp":1787118502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Zanthoxylum beecheyanum enhances vancomycin activity and inhibits biofilm formation in resistant staphylococcus aureus"],"prefix":"10.3389","volume":"17","author":[{"given":"Arshed","family":"Idrees","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy, College of Pharmacy, Mustansiriyah University","place":["Baghdad, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Salih","family":"Abbas","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, College of Pharmacy, Mustansiriyah University","place":["Baghdad, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University","place":["Clayton, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maytham","family":"Hussein","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University","place":["Clayton, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Velkov","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University","place":["Clayton, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2022_723","article-title":"Phytochemicals against drug-resistant bacterial biofilms and use of green extraction solvents to increase their bioactivity","volume":"1370","author":"Afonso","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/jpbs.JPBS_753_20","article-title":"Antimicrobial potential of naturally occurring bioactive secondary metabolites","volume":"13","author":"Allemailem","year":"2021","journal-title":"J. Pharm. Bioallied Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"B5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","article-title":"Definitions and guidelines for research on antibiotic persistence","volume":"17","author":"Balaban","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s42003-020-01530-y","article-title":"The antimicrobial potential of cannabidiol","volume":"4","author":"Blaskovich","year":"2021","journal-title":"Commun. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/INF.0000000000002992","article-title":"Reduced vancomycin susceptibility, MRSA and treatment failure in pediatric Staphylococcus aureus bloodstream infections","volume":"40","author":"Canty","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features","volume":"21","author":"Cong","year":"2020","journal-title":"J. Adv. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijantimicag.2005.09.002","article-title":"Antimicrobial activity of flavonoids","volume":"26","author":"Cushnie","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.3390\/molecules26144253","article-title":"Synthesis, antibacterial and antifungal activity of new 3-Aryl-5H-pyrrolo[1,2-a]imidazole and 5H-Imidazo[1,2-a]azepine Quaternary salts","volume":"26","author":"Demchenko","year":"2021","journal-title":"Molecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/molecules23030576","article-title":"GC-MS analysis of the composition of the essential oil from Dendranthema indicum Var. Aromaticum using three extraction methods and two columns","volume":"23","author":"Fan","year":"2018","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jgar.2014.04.006","article-title":"Vancomycin-intermediate resistance in Staphylococcus aureus","volume":"2","author":"Hiramatsu","year":"2014","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1128\/aac.00422-06","article-title":"Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia","volume":"50","author":"Howden","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e00077-20","DOI":"10.1128\/msystems.00077-20","article-title":"The killing mechanism of teixobactin against methicillin-resistant staphylococcus aureus: an untargeted metabolomics study","volume":"5","author":"Hussein","year":"2020","journal-title":"mSystems"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0100725","DOI":"10.1128\/aac.01007-25","article-title":"Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stress","volume":"69","author":"Hussein","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s44259-025-00168-2","article-title":"Metabolomics-driven prediction of antibiotic resistance: a perspective on pre-genetic intervention","volume":"3","author":"Hussein","year":"","journal-title":"NPJ Antimicrob. Resist"},{"key":"B19","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"CLSI Supplement M100","author":"Institute","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12866-024-03577-x","article-title":"Synergistic potential of Leu10-teixobactin and cefepime against multidrug-resistant Staphylococcus aureus","volume":"24","author":"Koh","year":"2024","journal-title":"BMC Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bse.2007.12.003","article-title":"Antimicrobial and insecticidal activities of essential oil isolated from Turkish salvia hydrangea DC. ex benth","volume":"36","author":"Kotan","year":"2008","journal-title":"Biochem. Syst. Ecol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.pharma.2026.01.003","article-title":"Phytochemical evaluation of Glossocardia bosvallia (Linn. F.) Dc.: a dual approach against resistant Staphylococcus aureus","volume":"84","author":"Kulandhaivel","year":"2026","journal-title":"Ann. Pharm. Fr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1039\/c6ra25894h","article-title":"The extraction of essential oils from patchouli leaves (Pogostemon cablin benth) using a microwave air-hydrodistillation method as a new green technique","volume":"7","author":"Kusuma","year":"2017","journal-title":"RSC Adv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3791\/2437","article-title":"Microtiter dish biofilm formation assay","author":"O'Toole","year":"2011","journal-title":"J. Vis. Exp."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.3390\/molecules26134023","article-title":"Zanthoxylum species: a comprehensive review of traditional uses, phytochemistry, pharmacological and nutraceutical applications","volume":"26","author":"Okagu","year":"","journal-title":"Molecules"},{"key":"B28","doi-asserted-by":"publisher","first-page":"713090","DOI":"10.3389\/fphar.2021.713090","article-title":"Zanthoxylum species: a review of traditional uses, phytochemistry and pharmacology in relation to cancer, infectious diseases and sickle cell anemia","volume":"12","author":"Okagu","year":"","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0023-2018","article-title":"Staphylococcal biofilms","volume":"6","author":"Otto","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9162","DOI":"10.1021\/acs.chemrev.6b00184","article-title":"Plant natural products targeting bacterial virulence factors","volume":"116","author":"Silva","year":"2016","journal-title":"Chem. Rev."},{"key":"B31","volume-title":"Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline","author":"Standards","year":"1999"},{"key":"B32","first-page":"259","article-title":"D-Limonene: safety and clinical applications","volume":"12","author":"Sun","year":"2007","journal-title":"Altern. Med. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B34","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically","author":"Weinstein","year":"2018"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e33207","DOI":"10.1016\/j.heliyon.2024.e33207","article-title":"Pharmacological activities of zanthoxylum L. plants and its exploitation and utilization","volume":"10","author":"Wen","year":"2024","journal-title":"Heliyon"},{"key":"B36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"116657","DOI":"10.1016\/j.lwt.2024.116657","article-title":"Utilization of nanoemulsion to enhance antibacterial capacity of Zanthoxylum bungeanum pericarp essential oils against foodborne pathogenic bacteria","volume":"207","author":"Zheng","year":"2024","journal-title":"LWT"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1919407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:48:23Z","timestamp":1787118503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1919407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":37,"alternative-id":["10.3389\/fphar.2026.1919407"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1919407","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1919407"}}